Skip to main content

Table 2 Potential role of intralesional monotherapy

From: Future perspectives in melanoma research “Melanoma Bridge”, Napoli, November 30th–3rd December 2016

Yes No
Not all patients are candidate for systemic therapy (co-morbidities, toxicity) Systemic therapies in 2015 are safe and effective
After progression on other therapies Melanoma is a systemic disease
Alternative to surgery? Surgery is an instant CR
Neoadjuvant potential Not yet proven